Cargando…
FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649458/ http://dx.doi.org/10.1186/2051-1426-3-S2-P354 |
| _version_ | 1782401362391203840 |
|---|---|
| author | Ring, Jennifer Li, Yajuan Shapiro, Irina Wang, Yan Weaver, David Pachter, Jonathan |
| author_facet | Ring, Jennifer Li, Yajuan Shapiro, Irina Wang, Yan Weaver, David Pachter, Jonathan |
| author_sort | Ring, Jennifer |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46494582015-11-24 FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy Ring, Jennifer Li, Yajuan Shapiro, Irina Wang, Yan Weaver, David Pachter, Jonathan J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649458/ http://dx.doi.org/10.1186/2051-1426-3-S2-P354 Text en Copyright © 2015 Ring et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Ring, Jennifer Li, Yajuan Shapiro, Irina Wang, Yan Weaver, David Pachter, Jonathan FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy |
| title | FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy |
| title_full | FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy |
| title_fullStr | FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy |
| title_full_unstemmed | FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy |
| title_short | FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy |
| title_sort | fak/pyk2 inhibitors defactinib and vs-4718 enhance immune checkpoint inhibitor efficacy |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649458/ http://dx.doi.org/10.1186/2051-1426-3-S2-P354 |
| work_keys_str_mv | AT ringjennifer fakpyk2inhibitorsdefactinibandvs4718enhanceimmunecheckpointinhibitorefficacy AT liyajuan fakpyk2inhibitorsdefactinibandvs4718enhanceimmunecheckpointinhibitorefficacy AT shapiroirina fakpyk2inhibitorsdefactinibandvs4718enhanceimmunecheckpointinhibitorefficacy AT wangyan fakpyk2inhibitorsdefactinibandvs4718enhanceimmunecheckpointinhibitorefficacy AT weaverdavid fakpyk2inhibitorsdefactinibandvs4718enhanceimmunecheckpointinhibitorefficacy AT pachterjonathan fakpyk2inhibitorsdefactinibandvs4718enhanceimmunecheckpointinhibitorefficacy |